BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6088161)

  • 1. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the efficacy of De-Nol and ranitidine in treating duodenal ulcer].
    Oproiu A; Pospai D; Cociaşu S; Oproiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(4):375-84. PubMed ID: 2905519
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 10. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
    Hollanders D; Morrissey SM; Mehta J
    Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
    [No Abstract]   [Full Text] [Related]  

  • 12. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Open study of ranitidine in short-term treatment of gastroduodenal ulcer].
    Varas MJ; Oliva I
    Rev Esp Enferm Apar Dig; 1984 Apr; 65(4):349-52. PubMed ID: 6330807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of sucralfate in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 Jan; 67(1):98-102. PubMed ID: 2716262
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
    Bell GD; Powell K; Burridge SM; Harrison G; Weil J; Gant PW; Jones PH; Trowell JE
    Aliment Pharmacol Ther; 1992 Jun; 6(3):327-33. PubMed ID: 1600049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the efficacy of ranitidine, cimetidine (Asiloc), De-Nol and spirulina in the treatment of gastric and duodenal ulcer].
    Fica V; Andronescu D; Olteanu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):21-35. PubMed ID: 2884709
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of tri-potassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer.
    Cipollini F; Altilia F
    Br J Clin Pract; 1987 Apr; 41(4):707-9. PubMed ID: 3689651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.